Matinas BioPharma Holdings Inc Share Price Other OTC
Equities
US5768101058
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 45.8M 3.53B |
---|---|---|---|---|---|
Net income 2024 * | -25M -1.93B | Net income 2025 * | -34M -2.62B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.83
x | P/E ratio 2025 * |
-1.66
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.47% |
Latest transcript on Matinas BioPharma Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 30/04/13 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 02/01/19 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 30/11/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 30/04/13 |
Natasha Giordano
BRD | Director/Board Member | 62 | 13/09/20 |
Eric Ende
CHM | Chairman | 55 | 02/04/17 |
1st Jan change | Capi. | |
---|---|---|
+20.12% | 127B | |
+24.61% | 117B | |
+25.44% | 27.67B | |
-17.72% | 20.33B | |
-15.17% | 16.79B | |
-15.20% | 15.63B | |
+11.81% | 14.84B | |
-47.10% | 14.65B | |
+54.58% | 14.43B |